Cell Therapy News Volume 13.12 | Apr 11 2022

    0
    26







    2022-07-11 | CTN 13.12


    Cell Therapy News by STEMCELL Technologies
    Vol. 13.12 – 11 April, 2022
    TOP STORY

    Functional Primordial Germ Cell-Like Cells from Pluripotent Stem Cells in Rats

    The authors demonstrated the induction of functional primordial germ cell-like cells (PGCLCs) from rat PSCs. They showed that epiblast-like cells in floating aggregates formed rat PGCLCs.
    [Science]

    AbstractPress Release
    Win an Immunology Podcast Bluetooth speaker!
    PUBLICATIONSRanked by the impact factor of the journal

    Human Pluripotent Stem Cell-Derived Myogenic Progenitors Undergo Maturation to Quiescent Satellite Cells upon Engraftment

    Using an myogenic progenitor cell (MPC)-specific fluorescent reporter system, scientists demonstrated that hPSC-derived MPCs could contribute to the regeneration of myofibers in mice following local injury and in mice deficient of dystrophin.
    [Cell Stem Cell]

    AbstractGraphical Abstract

    Delivery of CAR-T Cells in a Transient Injectable Stimulatory Hydrogel Niche Improves Treatment of Solid Tumors

    Researchers engineered simple-to-implement injectable hydrogels for the controlled co-delivery of CAR-T cells and stimulatory cytokines that improve treatment of solid tumors.
    [Science Advances]

    AbstractPress Release

    Injectable Adhesive Hemostatic Gel with Tumor Acidity Neutralizer and Neutrophil Extracellular Traps Lyase for Enhancing Adoptive NK Cell Therapy Prevents Post-Resection Recurrence of Hepatocellular Carcinoma

    A dual pH-responsive hydrogel with tumor acidity neutralizer and neutrophil extracellular traps lyase was developed and used in combination with natural killer cell infusion for preventing post-resection hepatocellular carcinom recurrence.
    [Biomaterials]

    Abstract

    Therapeutic Correction of Hemophilia A by Transplantation of hPSC-Derived Liver Sinusoidal Endothelial Cell Progenitors

    The authors developed an efficient and scalable protocol to produce hPSC-derived liver sinusoidal endothelial cells progenitors characterized as venous endothelial cells from different mesoderm subpopulations.
    [Cell Reports]

    Full ArticleGraphical Abstract

    CCR7 Expression in CD19 Chimeric Antigen Receptor-Engineered Natural Killer Cells Improves Migration toward CCL19-Expressing Lymphoma Cells and Increases Tumor Control in Mice with Human Lymphoma

    Since natural killer (NK)-92 cells do not spontaneously express CCR7, clinical-grade activated NK cells were transfected with a non-viral vector containing the CCR7 receptor, an anti-CD19 CAR and a high-affinity CD16 Fc receptor.
    [Cytotherapy]

    Abstract

    Transmural Myocardial Repair with Engineered Heart Muscle in a Rat Model of Heterotopic Heart Transplantation – a Proof-of-Concept Study

    Investigators tested the outcome after implantation of contractile engineered heart muscle and non-contractile engineered connective tissue as well as engineered mesenchymal tissue allografts as transmural heart wall replacement.
    [Journal of Molecular and Cellular Cardiology]

    AbstractGraphical Abstract

    Repeat Infusion of Autologous Bone Marrow Cells in Progressive Multiple Sclerosis – a Phase I Extension Study (SIAMMS II)

    ‘SIAMMS II’ was a prospective, single centre Phase I extension study in which participants in the SIAMMS study were offered repeat bone marrow harvest and infusion of autologous, unfractionated bone marrow as a day-case procedure.
    [Multiple Sclerosis and Related Disorders]

    Full Article

    In Vitro and In Vivo Assessment of a 3D Printable Gelatin Methacrylate Hydrogel for Bone Regeneration Applications

    Mesenchymal stem cells were encapsulated in the 3D printable GelMA ink, and their biological properties were assessed in vitro to evaluate their potential for cell delivery application.
    [Journal of Biomedical Materials Research Part B-Applied Biomaterials]

    Abstract

    An ISSCR 2021 Innovation Showcase Webinar: Quality by Design in hPSC Cell Therapy, presented by Lynn Csontos & Kimberly Snyder. Click to Watch Now.
    REVIEWS

    A Novel Glaucoma Approach: Stem Cell Regeneration of the Trabecular Meshwork

    Based on current knowledge of trabecular meshwork pathology in glaucoma and existing literature regarding stem cell regeneration of this tissue, scientists propose a human clinical study as the next step in understanding this potentially revolutionary treatment paradigm.
    [Progress in Retinal and Eye Research]

    Abstract

    Rewiring Mitochondrial Metabolism to Counteract Exhaustion of CAR-T Cells

    The authors review the mitochondrial characteristics of exhausted T cells and particularly discuss different aspects of mitochondrial metabolism and plasticity.
    [Journal of Hematology & Oncology]

    Full Article
    INDUSTRY AND POLICY NEWS

    Artiva Biotherapeutics Announces Agreement with Merck to Evaluate Combinations of NK Cells with Tri-Specific NK-Cell Engagers

    Artiva Biotherapeutics, Inc., an oncology company whose mission is to deliver highly effective, off-the-shelf, allogeneic natural killer cell therapies to treat cancer, announced that it has entered into an agreement with Merck, known as MSD outside the United States and Canada.
    [Artiva Biotherapeutics, Inc.]

    Press Release

    Japan Team Proves iPS-Based Cornea Transplant Safe in World-First Trial

    A Japanese university research team has concluded that the world’s first clinical trial, spanning over years, transplanting corneal tissues derived from iPSC, or iPS cells, into four almost-blind patients was safe and effective.
    [Kyodo News]

    Press Release
    FEATURED EVENT

    The 18th International HLA & Immunogenetics Workshop

    May 11 – 15, 2022
    Amsterdam, The Netherlands

    > See All Events

    JOB OPPORTUNITIES

    Technician – Cell Culture

    Novo Nordisk – Fremont, California, United States

    Research Scientist – Immuno Surveillance

    Francis Crick Institute – London, England, United Kingdom

    Postdoctoral Fellow Position – Translational Research

    Stanford University – Stanford, California, United States

    Science Writer – Blood Cancer

    Fred Hutchinson Cancer Research Center – Seattle, Washington, United States

    Postdoctoral Fellow – CAR-T Cell Exhaustion in Solid Tumors

    Fred Hutchinson Cancer Research Center – Seattle, Washington, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cell Therapy News Twitter